ArticleScientific reports2021

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.

Neel I Nissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.